Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 4 April 1986:
Vol. 232. no. 4746, pp. 61 - 65
DOI: 10.1126/science.2420009
Prev | Table of Contents | Next

Articles

Science, Vol 232, Issue 4746, 61-65
Copyright © 1986 by American Association for the Advancement of Science

articles

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

LM Souza, TC Boone, J Gabrilove, PH Lai, KM Zsebo, DC Murdock, VR Chazin, J Bruszewski, H Lu, KK Chen, and al. et

Experiments were conducted to isolate and characterize the gene and gene product of a human hematopoietic colony-stimulating factor with pluripotent biological activities. This factor has the ability to induce differentiation of a murine myelomonocytic leukemia cell line WEHI-3B(D+) and cells from patients with newly diagnosed acute nonlymphocytic leukemia (ANLL). A complementary DNA copy of the gene encoding a pluripotent human granulocyte colony-stimulating factor (hG-CSF) was cloned and expressed in Escherichia coli. The recombinant form of hG-CSF is capable of supporting neutrophil proliferation in a CFU-GM assay. In addition, recombinant hG-CSF can support early erythroid colonies and mixed colony formation. Competitive binding studies done with 125I-labeled hG-CSF and cell samples from two patients with newly diagnosed human leukemias as well as WEHI-3B(D+) cells showed that one of the human leukemias (ANLL, classified as M4) and the WEHI-3B(D+) cells have receptors for hG-CSF. Furthermore, the murine WEHI-3B(D+) cells and human leukemic cells classified as M2, M3, and M4 were induced by recombinant hG-CSF to undergo terminal differentiation to macrophages and granulocytes. The secreted form of the protein produced by the bladder carcinoma cell line 5637 was found to be O-glycosylated and to have a molecular weight of 19,600.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Development of a new G-CSF product based on biosimilarity assessment.
P. Gascon, U. Fuhr, F. Sorgel, M. Kinzig-Schippers, A. Makhson, S. Balser, S. Einmahl, and M. Muenzberg (2009)
Ann. Onc.
   Abstract »    Full Text »    PDF »
IL-1R Type I-Dependent Hemopoietic Stem Cell Proliferation Is Necessary for Inflammatory Granulopoiesis and Reactive Neutrophilia.
Y. Ueda, D. W. Cain, M. Kuraoka, M. Kondo, and G. Kelsoe (2009)
J. Immunol. 182, 6477-6484
   Abstract »    Full Text »    PDF »
Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor.
K.-H. Chuang, S. Altuwaijri, G. Li, J.-J. Lai, C.-Y. Chu, K.-P. Lai, H.-Y. Lin, J.-W. Hsu, P. Keng, M.-C. Wu, et al. (2009)
J. Exp. Med. 206, 1181-1199
   Abstract »    Full Text »    PDF »
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim in Subjects With Various Degrees of Renal Function.
B.-B. Yang, A. Kido, M. Salfi, S. Swan, and J. T. Sullivan (2008)
J. Clin. Pharmacol. 48, 1025-1031
   Abstract »    Full Text »    PDF »
Common acute oncological emergencies: diagnosis, investigation and management.
N Walji, A K Chan, and D R Peake (2008)
Postgrad. Med. J. 84, 418-427
   Abstract »    Full Text »    PDF »
Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis.
N. Berliner (2008)
Blood 111, 5427-5432
   Abstract »    Full Text »    PDF »
Hematopoietic cytokines.
D. Metcalf (2008)
Blood 111, 485-491
   Abstract »    Full Text »    PDF »
Pegfilgrastim-Induced Hyperleukocytosis.
R. L Snyder and D. J Stringham (2007)
Ann. Pharmacother. 41, 1524-1530
   Abstract »    Full Text »    PDF »
Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia.
T. Lehrnbecher, M. Zimmermann, D. Reinhardt, M. Dworzak, J. Stary, and U. Creutzig (2007)
Blood 109, 936-943
   Abstract »    Full Text »    PDF »
Does Granulocyte Colony-Stimulating Factor Worsen Anemia in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide?.
P. Papaldo, G. Ferretti, S. Di Cosimo, D. Giannarelli, P. Marolla, M. Lopez, E. Cortesi, M. Antimi, E. Terzoli, P. Carlini, et al. (2006)
J. Clin. Oncol. 24, 3048-3055
   Abstract »    Full Text »    PDF »
Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency.
M. Sohmiya, I. Kanazawa, and Y. Kato (2005)
Eur. J. Endocrinol. 152, 211-215
   Abstract »    Full Text »    PDF »
The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation.
C. R. D. Carter, K. M. Whitmore, and R. Thorpe (2004)
J. Leukoc. Biol. 75, 515-522
   Abstract »    Full Text »    PDF »
Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF delivery.
O. Yanay, S. C. Barry, L. J. Katen, M. Brzezinski, L. Y. Flint, J. Christensen, D. Liggitt, D. C. Dale, and W. R. A. Osborne (2003)
Blood 102, 2046-2052
   Abstract »    Full Text »    PDF »
Neutrophilia in LFA-1-Deficient Mice Confers Resistance to Listeriosis: Possible Contribution of Granulocyte-Colony-Stimulating Factor and IL-17.
M. Miyamoto, M. Emoto, Y. Emoto, V. Brinkmann, I. Yoshizawa, P. Seiler, P. Aichele, E. Kita, and S. H. E. Kaufmann (2003)
J. Immunol. 170, 5228-5234
   Abstract »    Full Text »    PDF »
Granulocyte colony-stimulating factor promotes adhesion of neutrophils.
A. Chakraborty, E. R. Hentzen, S. M. Seo, and C. W. Smith (2003)
Am J Physiol Cell Physiol 284, C103-C110
   Abstract »    Full Text »    PDF »
Proinflammatory Chemokine Induction in Keratocytes and Inflammatory Cell Infiltration into the Cornea.
J.-W. Hong, J. J. Liu, J.-S. Lee, R. R. Mohan, R. R. Mohan, D. J. Woods, Y.-G. He, and S. E. Wilson (2001)
Invest. Ophthalmol. Vis. Sci. 42, 2795-2803
   Abstract »    Full Text »    PDF »
Randomized Prospective Controlled Trial of Recombinant Granulocyte Colony-Stimulating Factor as Adjunctive Therapy for Limb-Threatening Diabetic Foot Infection.
F. de Lalla, G. Pellizzer, M. Strazzabosco, Z. Martini, G. Du Jardin, L. Lora, P. Fabris, P. Benedetti, and G. Erle (2001)
Antimicrob. Agents Chemother. 45, 1094-1098
   Abstract »    Full Text »    PDF »
Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized Trial.
R. Garcia-Carbonero, J. I. Mayordomo, M. V. Tornamira, M. Lopez-Brea, A. Rueda, V. Guillem, A. Arcediano, A. Yubero, F. Ribera, C. Gomez, et al. (2001)
J Natl Cancer Inst 93, 31-38
   Abstract »    Full Text »    PDF »
Safety and efficacy of recombinant granulocyte colony-stimulating factor as an adjunctive therapy for Streptococcus pneumoniae meningitis in non-neutropenic adult patients: a pilot study.
F. de Lalla, R. Nicolin, and L. Lazzarini (2000)
J. Antimicrob. Chemother. 46, 843-846
   Abstract »    Full Text »    PDF »
Late-Onset Neutropenia in Very Low Birth Weight Infants.
S. A. Omar, A. Salhadar, D. E. Wooliever, and P. K. Alsgaard (2000)
Pediatrics 106, 55e-55
   Abstract »    Full Text »
Angiotensin II Increases Host Resistance to Peritonitis.
K. Rodgers, S. Xiong, T. Espinoza, N. Roda, S. Maldonado, and G. S. diZerega (2000)
Clin. Vaccine Immunol. 7, 635-640
   Abstract »    Full Text »    PDF »
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation.
C. Zeidler, K. Welte, Y. Barak, F. Barriga, A. A. Bolyard, L. Boxer, G. Cornu, M. J. Cowan, D. C. Dale, T. Flood, et al. (2000)
Blood 95, 1195-1198
   Abstract »    Full Text »    PDF »
Production of Soluble Granulocyte Colony-Stimulating Factor Receptors from Myelomonocytic Cells.
H. Iwasaki, K. Shimoda, S. Okamura, T. Otsuka, K. Nagafuji, N. Harada, Y. Ohno, T. Miyamoto, K. Akashi, M. Harada, et al. (1999)
J. Immunol. 163, 6907-6911
   Abstract »    Full Text »    PDF »
Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis.
J.-i. Ashitani, H. Mukae, H. Taniguchi, T. Ihi, J.-i. Kadota, S. Kohno, and S. Matsukura (1999)
Thorax 54, 1015-1020
   Abstract »    Full Text »
Myeloid Colony-Stimulating Factors: Use in the Newborn.
C. Sreenan and H. Osiovich (1999)
Arch Pediatr Adolesc Med 153, 984-988
   Abstract »    Full Text »    PDF »
Human Granulocyte Colony-Stimulating Factor (G-CSF) Stimulates the In Vitro and In Vivo Development But Not Commitment of Primitive Multipotential Progenitors From Transgenic Mice Expressing the Human G-CSF Receptor.
F.-C. Yang, S. Watanabe, K. Tsuji, M.-j. Xu, A. Kaneko, Y. Ebihara, and T. Nakahata (1998)
Blood 92, 4632-4640
   Abstract »    Full Text »    PDF »
Recombinant human erythropoietin (rhEPO) in the management of anemia and fatigue associated with hematologic malignancies and the myelodysplastic syndromes.
T. G Davidson (1998)
Journal of Oncology Pharmacy Practice 4, S12-S17
   Abstract »    PDF »
Macrophage-Inflammatory Protein-3{beta}/EBI1-Ligand Chemokine/CK{beta}-11, a CC Chemokine, Is a Chemoattractant with a Specificity for Macrophage Progenitors Among Myeloid Progenitor Cells.
C. H. Kim, L. M. Pelus, J. R. White, and H. E. Broxmeyer (1998)
J. Immunol. 161, 2580-2585
   Abstract »    Full Text »    PDF »
Specific Signals Generated by the Cytoplasmic Domain of the Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Are Not Required for G-CSF-Dependent Granulocytic Differentiation.
J. Jacob, J. S. Haug, S. Raptis, and D. C. Link (1998)
Blood 92, 353-361
   Abstract »    Full Text »    PDF »
Granulocyte Colony-stimulating Factor Induces Neutrophil Sequestration in Rabbit Lungs.
H. Inano, S. Kameyama, S. Yasui, and A. Nagai (1998)
Am. J. Respir. Cell Mol. Biol. 19, 167-174
   Abstract »    Full Text »
A Randomized, Placebo-Controlled Trial of Granulocyte Colony-stimulating Factor Administration to Newborn Infants With Neutropenia and Clinical Signs of Early-onset Sepsis.
K. R. Schibler, K. A. Osborne, L. Y. Leung, T. V. Le, S. I. Baker, and D. D. Thompson (1998)
Pediatrics 102, 6-13
   Abstract »    Full Text »
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process.
M. Hallek, P. Leif Bergsagel, and K. C. Anderson (1998)
Blood 91, 3-21
   Full Text »    PDF »
Prevention of Thrombocytopenia and Neutropenia in a Nonhuman Primate Model of Marrow Suppressive Chemotherapy by Combining Pegylated Recombinant Human Megakaryocyte Growth and Development Factor and Recombinant Human Granulocyte Colony-Stimulating Factor.
L. A. Harker, U. M. Marzec, A. B. Kelly, E. Cheung, A. Tomer, J. L. Nichol, S. R. Hanson, and R. B. Stead (1997)
Blood 89, 155-165
   Abstract »    Full Text »    PDF »
Phosphorodithioate DNA as a potential therapeutic drug.
W. Marshall and M. Caruthers (1993)
Science 259, 1564-1570
   Abstract »    PDF »
Granulocyte Colony-Stimulating Factor Treatment of Antithyroid Drug-Induced Granulocytopenia.
J. Tajiri, S. Noguchi, S. Okamura, M. Morita, M. Tamaru, N. Murakami, and Y. Niho (1993)
Arch Intern Med 153, 509-514
   Abstract »    PDF »
Neutropenia in an Extremely Premature Infant Treated With Recombinant Human Granulocyte Colony-Stimulating Factor.
R. L. Roberts, C. M. Szelc, S. M. Scates, M. T. Boyd, K. M. Soderstrom, M. W. Davis, and J. A. Glaspy (1991)
Arch Pediatr Adolesc Med 145, 804-807
   Abstract »    PDF »
Protective Effect of Recombinant Human Granulocyte Colony-Stimulating Factor Against Pneumococcal Infections in Splenectomized Mice.
J. C. Hebert, M. O'Reilly, and R. L. Gamelli (1990)
Arch Surg 125, 1075-1078
   Abstract »    PDF »
Granulocyte Colony-Stimulating Factor and Neutrophil Alkaline Phosphatase.
T. Ushijima, Y. Ohbayashi, H. Sato, and A. Urabe (1989)
Ann Intern Med 111, 91
   Abstract »    PDF »
Treatment of Myelodysplastic Syndromes with Recombinant Human Granulocyte Colony-Stimulating Factor: A Phase I-II Trial.
R. S. Negrin, D. H. Haeuber, A. Nagler, L. C. Olds, T. Donlon, L. M. Souza, and P. L. Greenberg (1989)
Ann Intern Med 110, 976-984
   Abstract »    PDF »
Therapy for Neutropenia in Hairy Cell Leukemia with Recombinant Human Granulocyte Colony-Stimulating Factor.
J. A. Glaspy, G. C. Baldwin, P. A. Robertson, L. Souza, M. Vincent, J. Ambersley, and D. W. Golde (1988)
Ann Intern Med 109, 789-795
   Abstract »    PDF »
Recombinant Human Granulocyte Colony-Stimulating Factor and Pseudomonas Burn Wound Sepsis.
D. P. Mooney, R. L. Gamelli, M. O'Reilly, and J. C. Hebert (1988)
Arch Surg 123, 1353-1357
   Abstract »    PDF »
The molecular control of blood cell development.
L Sachs (1987)
Science 238, 1374-1379
   Abstract »    PDF »
The human hematopoietic colony-stimulating factors.
S. Clark and R Kamen (1987)
Science 236, 1229-1237
   Abstract »    PDF »
Assignment of the GM-CSF, CSF-1, and FMS Genes to Human Chromosome 5 Provides Evidence for Linkage of a Family of Genes Regulating Hematopoiesis and for Their Involvement in the Deletion (5q) in Myeloid Disorders.
M.M. Le Beau, M.J. Pettenati, R.S. Lemons, M.O. Diaz, C.A. Westbrook, R.A. Larson, C.J. Sherr, and J.D. Rowley (1986)
Cold Spring Harb Symp Quant Biol 51, 899-909
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)